Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
The UN's Economic and Social Commission for Asia and the Pacific (ESCAP), in cooperation with the China Disabled Persons Federation (CDPF), is organizing the High-level Intergovernmental Meeting on the Midpoint Review of the Asian and Pacific Decade of Persons with Disabilities, 2013-2022, in Beijing from 27 November to 1 December 2017.
Objectives of the Meeting are:
- To undertake a midpoint review of the progress made, including gaps and challenges, in the implementation of the Asian and Pacific Decade of Persons with Disabilities, 2013-2022, and the Incheon Strategy to Make the Right Real for Persons with Disabilities in Asia and the Pacific;
- To discuss the future policy direction for building disability-inclusive societies in Asia and the Pacific, bearing in mind the synergies between the Incheon Strategy and the 2030 Agenda for Sustainable Development as well as the Convention on the Rights of Persons with Disabilities;
- To consider and adopt an outcome document to accelerate the implementation of the Incheon Strategy for the remainder of the Decade.
The Meeting is to be held in pursuance of the Commission resolution 69/13 of 1 May 2013 on the Implementation of the Ministerial Declaration on the Asian and Pacific Decade of Persons with Disabilities, 2013-2022, and the Incheon Strategy to Make the Right Real for Persons with Disabilities in Asia and the Pacific.
The Meeting is taking place at a critical juncture when ESCAP member States and associate members are striving to build more inclusive societies at a time of global economic uncertainties and rising inequality, and the 2030 Agenda for Sustainable Development provides a unique opportunity to leave no one behind in development, and to support disability-inclusive development across Asia and the Pacific.
- Who is prone to vitiligo?
Scientists know that some people are genetically predisposed to a specific group of autoimmune diseases – including generalized vitiligo – but do not know who and why.It doesn’t...
- Does halo nevi affect vitiligo development?
Halo nevi — nevi with an depigmented circle around it, usually on the trunk — are about 10x more common in vitiligo patients than in the general population, especially in childr...
- What's better: laser or phototherapy?
In a recent study researchers assessed effect and safety of different laser and phototherapy treatments, such as excimer laser/light, narrowband UVB, UVA and PUVA. No significa...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.